Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD

AstraZeneca logo

AstraZeneca

Status

Completed

Conditions

GERD

Study type

Observational

Funder types

Industry

Identifiers

NCT00524355
NIS-GVN-NEX-2007/1
NIS-G84-GER-2007/2

Details and patient eligibility

About

To describe the frequency, type and severity of the symptoms in patients visiting the GI or internal physicians, with symptoms consistent with gastroesophageal reflux disease (GERD)

Enrollment

2,717 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients from both sexes, aged 18 years or older
  • Patients complaining of symptoms consistent with reflux disease

Exclusion criteria

Patients with GI cancer and those where the only reason for the visit is renewing the prescription are excluded

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems